Publications

As federal and state policymakers pursue policies to lower health care costs, “site neutral payment” has emerged as a potential tool with bipartisan support to bring down spending. Adopting “site neutral payments” would mean that a given service would cost the same amount regardless of where the care was received (i.e., the site of service)….

Blood cancers represent a range of diseases that can affect blood cells, bone marrow, lymph nodes, and other parts of the lymphatic system. Health care claims data can provide insights into how many people are dealing with blood cancers. Using claims data from people enrolled in Medicaid, employer-sponsored insurance (ESI), and Traditional Medicare, this data…

The high and rising costs of childbirth pose a financial challenge to many families. One study found that 60% of pregnant and postpartum women reported having difficulty affording care, with women enrolled in commercial insurance more likely to report affordability challenges than those with public insurance. To understand the average total spending on childbirth related…

Previously, HCCI analyzed Ozempic medication use in the ESI population and found that the percentage of patients using Ozempic that had a diabetes diagnosis, the condition Ozempic is clinically indicated to treat, had decreased from 92% in 2018 to 77% 2021. This indicated a growing trend of off-label use of Ozempic. Our findings aligned with…

Prior HCCI research has shown that women are more likely to use health care services than men. Among people who receive health insurance through their employer, we find that women are, on average, 1.4 times more likely to receive any health care services than men, and this trend has remained consistent over time. As shown…